Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study
Objective:
Approximately 50% to 70% of breast cancer survivors are affected by one or more symptoms of vulvovaginal atrophy (VVA). For those who cannot take hormone therapy, autologous platelet-rich plasma combined with hyaluronic acid (A-PRP-HA) may provide a new alternative therapy for the treatment of VVA in postmenopausal women with history of breast cancer.
Methods:
We enrolled 20 postmenopausal breast cancers survivors with VVA and a score of
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Alternative and Complementary Therapies | Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Men | Menopause | OBGYN | Study | Women